Latent tuberculosis infection - Revisiting and revising concepts

Tuberculosis

Volumn 95, Issue 4, 2015, Pages 373-384

  Salgame, Padmini ^a   Geadas, Carolina ^b   Collins, Lauren ^c   Jones López, Edward ^b   Ellner, Jerrold J ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Biomarkers; Diagnosis; Latent tuberculosis infection; Progression

Indexed keywords

BIOLOGICAL MARKER; VACCINE; BCG VACCINE;

AGE; ARTICLE; BACTERIAL STRAIN; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; CLINICAL FEATURE; COMORBIDITY; DIAGNOSTIC TEST; DISEASE COURSE; DISEASE PREDISPOSITION; EFFECTOR CELL; FLOW CYTOMETRY; GENETIC PREDISPOSITION; HIGH RISK PATIENT; HOST RESISTANCE; HUMAN; INTERFERON GAMMA RELEASE ASSAY; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MEDICAL HISTORY; MEMORY T LYMPHOCYTE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PATHOPHYSIOLOGY; POSTPRIMARY TUBERCULOSIS; PREVALENCE; PRIORITY JOURNAL; REINFECTION; RISK ASSESSMENT; T LYMPHOCYTE; TRANSCRIPTOMICS; TUBERCULIN TEST; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PREDICTIVE VALUE; PROGNOSIS; RISK FACTOR; VIRULENCE;

BIOMARKERS; DISEASE PROGRESSION; HOST-PATHOGEN INTERACTIONS; HUMANS; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; TUBERCULIN TEST; TUBERCULOSIS VACCINES; VIRULENCE;

EID: 84931578191     PISSN: 14729792     EISSN: 1873281X     Source Type: Journal    
DOI: 10.1016/j.tube.2015.04.003     Document Type: Review

References (164)

1. H. Hartman-Adams, K. Clark, and G. Juckett Update on latent tuberculosis infection Am Fam Physician 89 11 2014 889 896
2. Centers for Disease Control and Prevention (CDC) Basic TB facts, risk factors 2012 Available from: http://www.cdc.gov/tb/topic/basics/risk.htm
3. U. Mack, G.B. Migliori, and M. Sester LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement Eur Respir J 33 5 2009 956 973
4. M. Pai, C.M. Denkinger, and S.V. Kik Gamma interferon release assays for detection of Mycobacterium tuberculosis infection Clin Microbiol Rev 27 1 2014 3 20
5. S. Tagmouti, M. Slater, and A. Benedetti Reproducibility of interferon gamma (IFN-γ) release assays. A systematic review Ann Am Thorac Soc 11 8 2014 1267 1276
6. M. Pai, S.V. Kik, and N. Banaei Occupational screening for tuberculosis. A testing time for interferon-γ release assays Ann Am Thorac Soc 11 3 2014 399 401
7. S. Grzybowski, G. Barnett, and K. Styblo Contacts of cases of active pulmonary tuberculosis Bull Int Union Tuberc 50 1 1975 90 106
8. A.R. Escombe, D.A.J. Moore, and R.H. Gilman The infectiousness of tuberculosis patients coinfected with HIV PLoS Med 5 9 2008 e188
9. E.C. Jones-López, S. Kim, and G. Fregona Importance of cough and M. tuberculosis strain type as risks for increased transmission within households PLoS One 9 7 2014 e100984
10. E.C. Jones-López, O. Namugga, and F. Mumbowa Cough aerosols of Mycobacterium tuberculosis predict new infection: a household contact study Am J Respir Crit Care Med 187 9 2013 1007 1015
11. K.P. Fennelly, E.C. Jones-López, and I. Ayakaka Variability of infectious aerosols produced during coughing by patients with pulmonary tuberculosis Am J Respir Crit Care Med 186 5 2012 450 457
12. A.M. Dannenberg Roles of cytotoxic delayed-type hypersensitivity and macrophage-activating cell-mediated immunity in the pathogenesis of tuberculosis Immunobiology 191 4-5 1994 461 473
13. R.L. Riley Aerial dissemination of pulmonary tuberculosis Am Rev Tuberc 76 6 1957 931 941
14. D.W. Smith, and E.H. Wiegeshaus What animal models can teach us about the pathogenesis of tuberculosis in humans Rev Infect Dis Suppl. 2 1989 S385 S393
15. A. Cobat, C. Poirier, and E. Hoal Tuberculin skin test negativity is under tight genetic control of chromosomal region 11p14-15 in settings with different tuberculosis endemicities J Infect Dis 211 2 2015 317 321
16. K. Styblo The relationship between the risk of tuberculous infection and the risk of developing infectious tuberculosis Bull Int Union Tuberc Lung Dis 60 1985 117 119
17. F. Van Leth, M.J. van der Werf, and M.W. Borgdorff Prevalence of tuberculous infection and incidence of tuberculosis: a re-assessment of the styblo rule Bull World Health Organ 86 1 2008 20 26
18. S. Gagneux Genetic diversity in Mycobacterium tuberculosis Curr Top Microbiol Immunol 374 2013 1 25
19. C. Yang, T. Luo, and G. Sun Mycobacterium tuberculosis Beijing strains favor transmission but not drug resistance in China Clin Infect Dis 55 9 2012 1179 1187
20. A. Wallgren The time-table of tuberculosis Tubercle 29 11 1948 245 251
21. E. Lincoln, and E. Sewell Pathogenesis Tuberculosis in children 1963 McGraw-Hill New York, Blakiston Division 18 35
22. S.D. Lawn, R.J. Wilkinson, M.C.I. Lipman, and R. Wood Immune reconstitution and "unmasking" of tuberculosis during antiretroviral therapy Am J Respir Crit Care Med 177 7 2008 680 685
23. E. Vynnycky, and P.E. Fine The long-term dynamics of tuberculosis and other diseases with long serial intervals: implications of and for changing reproduction numbers Epidemiol Infect 121 2 1998 309 324
24. E. Lincoln, and A. Adiao Late discharge of tubercle bacilli in primary tuberculosis Am Rev Tuberc 79 1 1959 31 40
25. T. Gedde-Dahl Tuberculous infection in the light of tuberculin matriculation Am J Hyg 56 2 1952 139 214
26. P. Davies The natural history of tuberculosis in children. A study of child contacts in the Brompton Hospital Child Contact Clinic from 1930 to 1952 Tubercle 42 Suppl 1961 1 40
27. G. Comstock, V. Livesay, and S. Woolpert The prognosis of a positive tuberculin reaction in childhood and adolescence Am J Epidemiol 99 2 1974 131 138
28. G.J. Fox, S.E. Barry, W.J. Britton, and G.B. Marks Contact investigation for tuberculosis: a systematic review and meta-analysis Eur Respir J 41 1 2013 140 156
29. A.S. Pope, P.E. Sartwell, and D. Zacks Development of tuberculosis in infected children Am J Public Health Nations Health 29 12 1939 1318 1325
30. S. Grzybowski, and E. Allen The challenge of tuberculosis in decline. A study based on the epidemiology of tuberculosis in Ontario, Canada Am Rev Respir Dis 90 1964 707 720
31. D. Van Zwanenberg The influence of the number of bacilli on the development of tuberculous disease in children Am Rev Respir Dis 82 1960 31 44
32. S. Radhakrishna, T.R. Frieden, R. Subramani, T. Santha, and P.R. Narayanan Additional risk of developing TB for household members with a TB case at home at intake: a 15-year study Int J Tuberc Lung Dis 11 3 2007 282 288
33. E. Cruz-Ferro, M.I. Ursúa-Díaz, J.A. Taboada-Rodríguez, X. Hervada-Vidal, L. Anibarro, and V. Túñez Epidemiology of tuberculosis in Galicia, Spain, 16 years after the launch of the Galician tuberculosis programme Int J Tuberc Lung Dis 18 2 2014 134 140
34. V.N. Houk, J.H. Baker, K. Sorensen, and D.C. Kent The epidemiology of tuberculosis infection in a closed environment Arch Environ Health 16 1 1968 26 35
35. T. Berqvist, and S. Ernberg Zur frage der tuberkulosen primary inffektion bei jungen erwachsen Acta Med Scand 115 1943 57 82
36. H. Malmros, and E. Hedval Studien ber die Enstehung und Entwicklung der Lungentuberkulose J Ambrosius Barth Leipz 1938
37. C.L. Daley, P.M. Small, and G.F. Schecter An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms N Engl J Med 326 4 1992 231 235
38. J. Keane, S. Gershon, and R.P. Wise Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent N Engl J Med 345 15 2001 1098 1104
39. M.W. Borgdorff, M. Sebek, R.B. Geskus, K. Kremer, N. Kalisvaart, and D. van Soolingen The incubation period distribution of tuberculosis estimated with a molecular epidemiological approach Int J Epidemiol 40 4 2011 964 970
40. O.R. McCarthy Asian immigrant tuberculosis - the effect of visiting Asia Br J Dis Chest 78 1984 248 253
41. T. Cohen, and M. Murray Incident tuberculosis among recent US immigrants and exogenous reinfection Emerg Infect Dis 11 5 2005 725 728
42. T. Oni, R. Burke, and R. Tsekela High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening Thorax 66 8 2011 669 673
43. C.C. Whalen, J.L. Johnson, and A. Okwera A trial of three regimens to prevent tuberculosis in Ugandan adults infected with the human immunodeficiency virus. Uganda-Case Western Reserve University Research Collaboration N Engl J Med 337 12 1997 801 808
44. J.J. Gómez-Reino, L. Carmona, and M. Angel Descalzo Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection Arthritis Rheum 57 5 2007 756 761
45. I. Martínez-Pino, M.A. Sambeat, J.R. Lacalle-Remigio, and P. Domingo Incidence of tuberculosis in HIV-infected patients in Spain: the impact of treatment for LTBI Int J Tuberc Lung Dis 17 12 2013 1545 1551
46. L. Elzi, M. Schlegel, and R. Weber Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission Clin Infect Dis 44 1 2007 94 102
47. C.R. Horsburgh Priorities for the treatment of latent tuberculosis infection in the United States N Engl J Med 350 20 2004 2060 2067
48. J. Vaara, and K. Kokkola Inactive pulmonary lesions: a potent risk factor of tuberculosis Ann Clin Res 7 5 1975 331 333
49. W.W. Stead Pathogenesis of the sporadic case of tuberculosis N Engl J Med 277 19 1967 1008 1012
50. K.A. Millington, S. Gooding, T.S.C. Hinks, D.J.M. Reynolds, and A. Lalvani Mycobacterium tuberculosis-specific cellular immune profiles suggest bacillary persistence decades after spontaneous cure in untreated tuberculosis J Infect Dis 202 11 2010 1685 1689
51. S.N. Bass, P.J. Spagnuolo, and J.J. Ellner Augmented neutrophil adherence in active and remote tuberculosis Am Rev Respir Dis 124 5 1981 643 645
52. N.T.T. Thuong, T.R. Hawn, and G.E. Thwaites A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis Genes Immun 8 5 2007 422 428
53. J.A. Shah, J.C. Vary, and T.T.H. Chau Human TOLLIP regulates TLR2 and TLR4 signaling and its polymorphisms are associated with susceptibility to tuberculosis J Immunol 189 4 2012 1737 1746
54. D.M. Tobin, J.C. Vary, and J.P. Ray The lta4h locus modulates susceptibility to mycobacterial infection in zebrafish and humans Cell 140 5 2010 717 730
55. D.M. Tobin, F.J. Roca, and S.F. Oh Host genotype-specific therapies can optimize the inflammatory response to mycobacterial infections Cell 148 3 2012 434 446
56. A. Lalvani, M.A. Behr, and S. Sridhar Innate immunity to TB: a druggable balancing act Cell 148 3 2012 389 391
57. K.D. Mayer-Barber, B.B. Andrade, and S.D. Oland Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk Nature 511 7507 2014 99 103
58. A.K. Coussens, R.J. Wilkinson, and Y. Hanifa Vitamin D accelerates resolution of inflammatory responses during tuberculosis treatment Proc Natl Acad Sci U S A 109 38 2012 15449 15454
59. A. Douglas, S. Ali, and S. Bakhshi Does vitamin D deficiency account for ethnic differences in tuberculosis seasonality in the UK? Ethn Health 3 4 1998 247 253
60. R.M.B. Teles, T.G. Graeber, and S.R. Krutzik Type I interferon suppresses type II interferon-triggered human anti-mycobacterial responses Science 339 6126 2013 1448 1453
61. J.R. Andrews, F. Noubary, R.P. Walensky, R. Cerda, E. Losina, and C.R. Horsburgh Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis Clin Infect Dis 54 6 2012 784 791
62. E. Brooks-Pollock, M.C. Becerra, E. Goldstein, T. Cohen, and M.B. Murray Epidemiologic inference from the distribution of tuberculosis cases in households in Lima Peru J Infect Dis 203 11 2011 1582 1589
63. E. Vynnycky, and P.E. Fine The natural history of tuberculosis: the implications of age-dependent risks of disease and the role of reinfection Epidemiol Infect 119 2 1997 183 201
64. C.C. Whalen, S. Zalwango, and A. Chiunda Secondary attack rate of tuberculosis in urban households in Kampala, Uganda PLoS One 6 2 2011 e16137
65. F.M. Marx, R. Dunbar, and D.A. Enarson The temporal dynamics of relapse and reinfection tuberculosis after successful treatment: a retrospective cohort study Clin Infect Dis 58 12 2014 1676 1683
66. J.J. Ellner Immunoregulation in TB: observations and implications Clin Transl Sci 3 1 2010 23 28
67. J.D. Mancuso, J. Bernardo, and G.H. Mazurek The elusive "gold" standard for detecting Mycobacterium tuberculosis infection Am J Respir Crit Care Med 187 2 2013 122 124
68. J.Z. Metcalfe, A. Cattamanchi, C.E. McCulloch, J.D. Lew, N.P. Ha, and E.A. Graviss Test variability of the QuantiFERON-TB gold in-tube assay in clinical practice Am J Respir Crit Care Med 187 2 2013 206 211
69. R.N. Van Zyl-Smit, M. Pai, and K. Peprah Within-subject variability and boosting of T-cell interferon-gamma responses after tuberculin skin testing Am J Respir Crit Care Med 180 1 2009 49 58
70. L. Bradshaw, E. Davies, and M. Devine The role of the interferon gamma release assay in assessing recent tuberculosis transmission in a hospital incident PLoS One 6 6 2011 e20770
71. A.K. Detjen, L. Loebenberg, and H.M.S. Grewal Short-term reproducibility of a commercial interferon gamma release assay Clin Vaccine Immunol 16 8 2009 1170 1175
72. F.C. Ringshausen, A. Nienhaus, and J. Torres Costa Within-subject variability of Mycobacterium tuberculosis-specific gamma interferon responses in German health care workers Clin Vaccine Immunol 18 7 2011 1176 1182
73. R.D. Powell, W.C. Whitworth, J. Bernardo, P.K. Moonan, and G.H. Mazurek Unusual interferon gamma measurements with QuantiFERON-TB gold and QuantiFERON-TB gold in-tube tests PLoS One 6 6 2011 e20061
74. A. Zwerling, A. Benedetti, and M. Cojocariu Repeat IGRA testing in Canadian health workers: conversions or unexplained variability? PLoS One 8 1 2013 e54748
75. S.E. Dorman, R. Belknap, and E.A. Graviss Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States Am J Respir Crit Care Med 189 1 2014 77 87
76. M.L. Slater, G. Welland, M. Pai, J. Parsonnet, and N. Banaei Challenges with QuantiFERON-TB gold assay for large-scale, routine screening of U.S. healthcare workers Am J Respir Crit Care Med 188 8 2013 1005 1010
77. M. Pai, R. Joshi, and S. Dogra T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India Int J Tuberc Lung Dis 13 1 2009 84 92
78. P.C. Hill, R.H. Brookes, and A. Fox Longitudinal assessment of an ELISPOT test for Mycobacterium tuberculosis infection PLoS Med 4 6 2007 e192
79. M. Shah, T.S. Kasambira, P.V. Adrian, S.A. Madhi, N.A. Martinson, and S.E. Dorman Longitudinal analysis of QuantiFERON-TB gold in-tube in children with adult household tuberculosis contact in South Africa: a prospective cohort study PLoS One 6 10 2011 e26787
80. D. Menzies Interpretation of repeated tuberculin tests: boosting, conversion, and reversion Am J Respir Crit Care Med 159 1999 15 21
81. R.E. Huebner, M.F. Schein, and J.B. Bass The tuberculin skin test Clin Infect Dis 17 6 1993 968 975
82. P.E. Fine, J. Bruce, J.M. Ponnighaus, P. Nkhosa, A. Harawa, and E. Vynnycky Tuberculin sensitivity: conversions and reversions in a rural African population Int J Tuberc Lung Dis 3 11 1999 962 975
83. J.L. Johnson, S. Nyole, and A. Okwera Instability of tuberculin and Candida skin test reactivity in HIV-infected Ugandans. The Uganda-Case Western Reserve University Research Collaboration Am J Respir Crit Care Med 158 6 1998 1790 1796
84. R. Ribeiro-Rodrigues, S. Kim, and F.D. Coelho da Silva Discordance of tuberculin skin test and interferon gamma release assay in recently exposed household contacts of pulmonary TB cases in Brazil PLoS One 9 5 2014 e96564
85. S.W. Lee, D.K. Oh, S.H. Lee, H.Y. Kang, C.-T. Lee, and J.-J. Yim Time interval to conversion of interferon-γ release assay after exposure to tuberculosis Eur Respir J 37 6 2011 1447 1452
86. L. Anibarro, M. Trigo, C. Villaverde, A. Pena, and A. González-Fernández Tuberculin skin test and interferon-γ release assay show better correlation after the tuberculin "window period" in tuberculosis contacts Scand J Infect Dis 43 6-7 2011 424 429
87. Centers for Disease Control and Prevention (CDC) Guidelines for the investigation of contacts of persons with infectious tuberculosis. Recommendations from the National Tuberculosis Controllers Association and CDC. Guidelines for using the QuantiFERON®-T Morb Mortal Wkly Rep 54 No. RR-15 2005 3-6, 51-4
88. A.C. Hesseling, A.M. Mandalakas, and H.L. Kirchner Highly discordant T cell responses in individuals with recent exposure to household tuberculosis Thorax 64 10 2009 840 846
89. I.M.O. Adetifa, M.D. Lugos, and A. Hammond Comparison of two interferon gamma release assays in the diagnosis of Mycobacterium tuberculosis infection and disease in the Gambia BMC Infect Dis 7 2007 122
90. A.O. Shakak, E. Awad, and G. Khalil Prevalence of latent tuberculosis infection in Sudan: a case-control study comparing interferon-γ release assay and tuberculin skin test BMC Public Health 13 1128 2013
91. P.C. Hill, A. Fox, and D.J. Jeffries Quantitative T cell assay reflects infectious load of Mycobacterium tuberculosis in an endemic case contact model Clin Infect Dis Off Publ Infect Dis Soc Am 40 2 2005 273 278
92. D. Ozdemir, A.N. Annakkaya, and G. Tarhan Comparison of the tuberculin skin test and the quantiferon test for latent Mycobacterium tuberculosis infections in health care workers in Turkey Jpn J Infect Dis 60 2-3 2007 102 105
93. R. Diel, R. Loddenkemper, and A. Nienhaus Predictive value of interferon-γ release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis Chest 142 1 2012 63 75
94. H. Mahomed, T. Hawkridge, and S. Verver The tuberculin skin test versus QuantiFERON TB gold® in predicting tuberculosis disease in an adolescent cohort study in South Africa PLoS One 6 3 2011 e17984
95. M.X. Rangaka, K.A. Wilkinson, and J.R. Glynn Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis Lancet Infect Dis 12 1 2012 45 55
96. I.M.O. Adetifa, M.O.C. Ota, and B. Walther Decay kinetics of an interferon gamma release assay with anti-tuberculosis therapy in newly diagnosed tuberculosis cases PLoS One 5 9 2010
97. C.B.E. Chee, K.W. KhinMar, S.H. Gan, T.M.S. Barkham, M. Pushparani, and Y.T. Wang Latent tuberculosis infection treatment and T-cell responses to Mycobacterium tuberculosis-specific antigens Am J Respir Crit Care Med 175 3 2007 282 287
98. S.H. Lee, W.J. Lew, and H.J. Kim Serial interferon-gamma release assays after rifampicin prophylaxis in a tuberculosis outbreak Respir Med 104 3 2010 448 453
99. R.E. Watkins, R. Brennan, and A.J. Plant Tuberculin reactivity and the risk of tuberculosis: a review Int J Tuberc Lung Dis 4 10 2000 895 903
100. K. Higuchi, N. Harada, K. Fukazawa, and T. Mori Relationship between whole-blood interferon-gamma responses and the risk of active tuberculosis Tuberc (Edinb) 88 3 2008 244 248
101. J.Z. Metcalfe, A. Cattamanchi, and E. Vittinghoff Evaluation of quantitative IFN-gamma response for risk stratification of active tuberculosis suspects Am J Respir Crit Care Med 181 1 2010 87 93
102. H. Mahomed, T. Hawkridge, and S. Verver The tuberculin skin test versus QuantiFERON TB Gold® in predicting tuberculosis disease in an adolescent cohort study in South Africa PLoS One 6 3 2011 e17984
103. R. Diel, R. Loddenkemper, S. Niemann, K. Meywald-Walter, and A. Nienhaus Negative and positive predictive value of a whole-blood interferon-γ release assay for developing active tuberculosis: an update Am J Respir Crit Care Med 183 1 2011 88 95
104. C.L. Day, D.A. Abrahams, and L. Lerumo Functional capacity of Mycobacterium tuberculosis-specific T cell responses in humans is associated with mycobacterial load J Immunol 187 5 2011 2222 2232
105. D. Kaushal, S. Mehra, P.J. Didier, and A.A. Lackner The non-human primate model of tuberculosis J Med Primatol 41 3 2012 191 201
106. S. Mehra, N.A. Golden, and N.K. Dutta Reactivation of latent tuberculosis in rhesus macaques by coinfection with simian immunodeficiency virus J Med Primatol 40 4 2011 233 243
107. J.A. Myers, J.E. Bearman, and H.G. Dixon Natural history of tuberculosis in the human body. Prognosis among tuberculin reactor children of six to twelve years Am Rev Respir Dis 90 1964 359 369
108. D.F. Johnson, L.L. Malone, and S. Zalwango Tuberculin skin test reversion following isoniazid preventive therapy reflects diversity of immune response to primary Mycobacterium tuberculosis infection PLoS One 9 5 2014 e96613
109. D.V. Havlir, F. van der Kuyp, E. Duffy, R. Marshall, D. Hom, and J.J. Ellner A 19-year follow-up of tuberculin reactors. Assessment of skin test reactivity and in vitro lymphocyte responses Chest 99 5 1991 1172 1176
110. J.C. Choi, J.W. Shin, J.Y. Kim, I.W. Park, B.W. Choi, and M.-K. Lee The effect of previous tuberculin skin test on the follow-up examination of whole-blood interferon-γ assay in the screening for latent tuberculosis infection Chest 133 6 2008 1415 1420
111. C. Vilaplana, J. Ruiz-Manzano, and O. Gil The tuberculin skin test increases the responses measured by T cell interferon-gamma release assays Scand J Immunol 67 6 2008 610 617
112. E.M.S. Leyten, C. Prins, and A.W. Bossink Effect of tuberculin skin testing on a Mycobacterium tuberculosis-specific interferon-γ assay Eur Respir J 29 6 2007 1212 1216
113. R.N. Van Zyl-Smit, A. Zwerling, K. Dheda, and M. Pai Within-subject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review PLoS One 4 12 2009 e8517
114. A. Naseer, S. Naqvi, and B. Kampmann Evidence for boosting Mycobacterium tuberculosis-specific IFN-γ responses at 6 weeks following tuberculin skin testing Eur Respir J 29 6 2007 1282 1283
115. L. Richeldi, B.M. Bergamini, and F. Vaienti Prior tuberculin skin testing does not boost QuantiFERON-TB results in paediatric contacts Eur Respir J 32 2 2008 523 524
116. L.J. Abu-Raddad, L. Sabatelli, and J.T. Achterberg Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics Proc Natl Acad Sci U S A 106 33 2009 13980 13985
117. R. Mistry, J.M. Cliff, and C.L. Clayton Gene-expression patterns in whole blood identify subjects at risk for recurrent tuberculosis J Infect Dis 195 3 2007 357 365
118. J. Maertzdorf, D. Repsilber, and S.K. Parida Human gene expression profiles of susceptibility and resistance in tuberculosis Genes Immun 12 1 2011 15 22
119. M.P.R. Berry, C.M. Graham, and F.W. McNab An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis Nature 466 7309 2010 973 977
120. J. Maertzdorf, J. Weiner, and H.-J. Mollenkopf Common patterns and disease-related signatures in tuberculosis and sarcoidosis Proc Natl Acad Sci U S A 109 20 2012 7853 7858
121. T.H.M. Ottenhoff, R.H. Dass, and N. Yang Genome-wide expression profiling identifies type 1 interferon response pathways in active tuberculosis PLoS One 7 9 2012 e45839
122. J. Maertzdorf, M. Ota, and D. Repsilber Functional correlations of pathogenesis-driven gene expression signatures in tuberculosis PLoS One 6 10 2011 e26938
123. E. Lesho, F.J. Forestiero, and M.H. Hirata Transcriptional responses of host peripheral blood cells to tuberculosis infection Tuberc (Edinb) 91 5 2011 390 399
124. R. Colangeli, V.L. Arcus, and R.T. Cursons Whole genome sequencing of Mycobacterium tuberculosis reveals slow growth and low mutation rates during latent infections in humans PLoS One 9 3 2014 e91024
125. S.M. Kaech, and E.J. Wherry Heterogeneity and cell-fate decisions in effector and memory CD8+ T cell differentiation during viral infection Immunity 27 3 2007 393 405
126. J.D. Miller, R.G. van der Most, and R.S. Akondy Human effector and memory CD8+ T cell responses to smallpox and yellow fever vaccines Immunity 28 5 2008 710 722
127. J.M. Bustamante, L.M. Bixby, and R.L. Tarleton Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease Nat Med 14 5 2008 542 550
128. C. Steel, and T.B. Nutman Altered T cell memory and effector cell development in chronic lymphatic filarial infection that is independent of persistent parasite antigen PLoS One 6 4 2011 e19197
129. E. Matteucci, M. Ghimenti, S. Di Beo, and O. Giampietro Altered proportions of naïve, central memory and terminally differentiated central memory subsets among CD4+ and CD8 + T cells expressing CD26 in patients with type 1 diabetes J Clin Immunol 31 6 2011 977 984
130. L.G. Tussey, U.S. Nair, and M. Bachinsky Antigen burden is major determinant of human immunodeficiency virus-specific CD8+ T cell maturation state: potential implications for therapeutic immunization J Infect Dis 187 3 2003 364 374
131. A. Harari, F. Vallelian, and G. Pantaleo Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load Eur J Immunol 34 12 2004 3525 3533
132. P. Tapaninen, A. Korhonen, L. Pusa, I. Seppälä, and T. Tuuminen Effector memory T-cells dominate immune responses in tuberculosis treatment: antigen or bacteria persistence? Int J Tuberc Lung Dis 14 3 2010 347 355
133. T. Adekambi, C.C. Ibegbu, A.S. Kalokhe, T. Yu, S.M. Ray, and J. Rengarajan Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis PLoS One 7 4 2012 e36046
134. C.S. Lindestam Arlehamn, A. Gerasimova, and F. Mele Memory T cells in latent Mycobacterium tuberculosis infection are directed against three antigenic islands and largely contained in a CXCR3+CCR6+ Th1 subset PLoS Pathog 9 1 2013 e1003130
135. J. Walrath, L. Zukowski, A. Krywiak, and R.F. Silver Resident Th1-like effector memory cells in pulmonary recall responses to Mycobacterium tuberculosis Am J Respir Cell Mol Biol 33 1 2005 48 55
136. E. Petruccioli, L. Petrone, and V. Vanini IFNγ/TNFα specific-cells and effector memory phenotype associate with active tuberculosis J Infect 66 6 2013 475 486
137. T. Chiacchio, E. Petruccioli, and V. Vanini Polyfunctional T-cells and effector memory phenotype are associated with active TB in HIV-infected patients J Infect 69 6 2014 533 545
138. T. Adekambi, C.C. Ibegbu, and S. Cagle Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response J Clin Invest 125 5 2015 1827 1838
139. N. Caccamo, G. Guggino, and S.A. Joosten Multifunctional CD4(+) T cells correlate with active Mycobacterium tuberculosis infection Eur J Immunol 40 8 2010 2211 2220
140. P.K. Drain, L. Mayeza, and P. Bartman Diagnostic accuracy and clinical role of rapid C-reactive protein testing in HIV-infected individuals with presumed tuberculosis in South Africa Int J Tuberc Lung Dis 18 1 2014 20 26
141. G. Vanham, K. Edmonds, and L. Qing Generalized immune activation in pulmonary tuberculosis: co-activation with HIV infection Clin Exp Immunol 103 1 1996 30 34
142. L.E. Hanna, K. Nayak, S. Subramanyam, P. Venkatesan, P.R. Narayanan, and S. Swaminathan Incomplete immunological recovery following anti-tuberculosis treatment in HIV-infected individuals with active tuberculosis Indian J Med Res 129 5 2009 548 554
143. J.F. Djoba Siawaya, M. Ruhwald, J. Eugen-Olsen, and G. Walzl Correlates for disease progression and prognosis during concurrent HIV/TB infection Int J Infect Dis 11 4 2007 289 299
144. A. Azzurri, O.Y. Sow, and A. Amedei IFN-gamma-inducible protein 10 and pentraxin 3 plasma levels are tools for monitoring inflammation and disease activity in Mycobacterium tuberculosis infection Microbes Infect 7 1 2005 1 8
145. J. Eugen-Olsen, P. Gustafson, and N. Sidenius The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau Int J Tuberc Lung Dis 6 8 2002 686 692
146. T. Demir, C. Yalçinoz, I. Keskinel, F. Demiröz, and N. Yildirim sICAM-1 as a serum marker in the diagnosis and follow-up of treatment of pulmonary tuberculosis Int J Tuberc Lung Dis 6 2 2002 155 159
147. H. Mukae, J. Ashitani, M. Tokojima, T. Ihi, S. Kohno, and S. Matsukura Elevated levels of circulating adhesion molecules in patients with active pulmonary tuberculosis Respirology 8 3 2003 326 331
148. Y. Koguchi, K. Kawakami, and K. Uezu High plasma osteopontin level and its relationship with interleukin-12-mediated type 1 T helper cell response in tuberculosis Am J Respir Crit Care Med 167 10 2003 1355 1359
149. C.S. Hirsch, R. Hussain, Z. Toossi, G. Dawood, F. Shahid, and J.J. Ellner Cross-modulation by transforming growth factor beta in human tuberculosis: suppression of antigen-driven blastogenesis and interferon gamma production Proc Natl Acad Sci U S A 93 8 1996 3193 3198
150. M.A. De Groote, P. Nahid, and L. Jarlsberg Elucidating novel serum biomarkers associated with pulmonary tuberculosis treatment PLoS One 8 4 2013 e61002
151. S. Mahapatra, A.M. Hess, and J.L. Johnson A metabolic biosignature of early response to anti-tuberculosis treatment BMC Infect Dis 14 2014 53
152. S. Kunnath-Velayudhan, H. Salamon, and H.-Y. Wang Dynamic antibody responses to the Mycobacterium tuberculosis proteome Proc Natl Acad Sci U S A 107 33 2010 14703 14708
153. H.-R. Kim, S.S. Hwang, and H.J. Kim Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis Clin Infect Dis 45 10 2007 1290 1295
154. I.-J. Kim, J.S. Lee, and S.-J. Kim Double-phase 18F-FDG PET-CT for determination of pulmonary tuberculoma activity Eur J Nucl Med Mol Imaging 35 4 2008 808 814
155. Y. Demura, T. Tsuchida, and D. Uesaka Usefulness of 18F-fluorodeoxyglucose positron emission tomography for diagnosing disease activity and monitoring therapeutic response in patients with pulmonary mycobacteriosis Eur J Nucl Med Mol Imaging 36 4 2009 632 639
156. A. Kwan, M. Seltzer, J. Czernin, M.J. Chou, and C.H. Kao Characterization of hilar lymph node by 18F-fluoro-2-deoxyglucose positron emission tomography in healthy subjects Anticancer Res 21 1B 2001 701 706
157. D.-W. Kim, and C.G. Kim Dual-time point positron emission tomography findings of benign mediastinal lymph nodes in a tuberculosis-endemic region Jpn J Radiol 29 10 2011 682 687
158. N. Ghesani, A. Patrawalla, A. Lardizabal, P. Salgame, and K.P. Fennelly Increased cellular activity in thoracic lymph nodes in early human latent tuberculosis infection Am J Respir Crit Care Med 189 6 2014 748 750
159. C.C. Whalen, A. Chiunda, and S. Zalwango Immune correlates of acute Mycobacterium tuberculosis infection in household contacts in Kampala, Uganda Am J Trop Med Hyg 75 1 2006 55 61
160. C.F. Von Reyn, L. Mtei, and R.D. Arbeit Prevention of tuberculosis in Bacille Calmette-Guérin-primed, HIV-infected adults boosted with an inactivated whole-cell mycobacterial vaccine AIDS 24 5 2010 675 685
161. J. Houghton, T. Cortes, and O. Schubert A small RNA encoded in the Rv2660c locus of Mycobacterium tuberculosis is induced during starvation and infection PLoS One 8 12 2013 e80047
162. P.L. Lin, J. Dietrich, and E. Tan The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection J Clin Invest 122 1 2012 303 314
163. S.H.E. Kaufmann, C. Lange, and M. Rao Progress in tuberculosis vaccine development and host-directed therapies - a state of the art review Lancet Respir Med 2 4 2014 301 320
164. H. Esmail, C.E. Barry, D.B. Young, and R.J. Wilkinson The ongoing challenge of latent tuberculosis Philos Trans R Soc Lond B Biol Sci 369 1645 2014 20130437